NISCO International Inc is biotechnology company spun out of Mayo clinic and is focused on the research and development of novel therapeutics in oncology and other unmet medical needs. principals of the firm are genetically modifying the measles virus to treat mesothelioma, a deadly lung disease. The Partnership formed Nisco, a start-up to commercialize their research. In 2010 it was reported that human clinical trials begin in a few months.
